Stop the medication and contact your prescriber right away. Methylphenidate-induced hallucinations are an uncommon but well-documented side effect, and in the published case literature, the symptoms typically resolve once the drug is discontinued. The experience can be deeply unsettling, especially for children, who make up the majority of reported cases. Knowing how to respond in the moment, what to expect afterward, and whether stimulant treatment can safely resume are all questions that deserve clear answers.
What These Hallucinations Typically Look Like
The hallucinations that methylphenidate can trigger are not like the disorganized perceptions associated with schizophrenia. They tend to follow a surprisingly specific pattern, particularly in children. An FDA analysis of postmarketing reports and clinical trial data found that hallucinations involving visual or tactile sensations of insects, snakes, or worms were common among pediatric cases.1Pediatrics. Hallucinations and Other Psychotic Symptoms Associated With the Use of Attention-Deficit/Hyperactivity Disorder Drugs in Children A child might see bugs crawling on the floor, feel worms under the skin, or perceive small animals running around a room. One published case describes a fifteen-year-old boy who, after a single low dose of methylphenidate, experienced vivid hallucinations of rats running around and touching and smelling him.2PubMed. Methylphenidate induction of complex visual hallucinations
Researchers have characterized these as “visual-tactile phobic hallucinations,” where the visual and touch components overlap and the content is frightening. Case reports describe these episodes as a distinct phenomenon that occurs in otherwise neurologically healthy children, without underlying metabolic or structural brain problems.3PubMed Central. Visual-Tactile Phobic Hallucinations in a Child With Stimulant-Managed Attention-Deficit/Hyperactivity Disorder (ADHD) That matters because it means these episodes are not a sign that a child “has psychosis” in the clinical sense. They are a pharmacological reaction, and they typically end when the drug is removed.
The First Thing to Do
If you or your child starts hallucinating while taking methylphenidate, do not give the next dose. Call your prescribing doctor as soon as possible. In many cases, the hallucinations happen during the first days or weeks of treatment, sometimes even after a single dose. The prescriber will almost certainly tell you to stop the medication immediately.
Whether you need to go to the emergency room depends on how severe the symptoms are. A consensus guideline on methylphenidate-related adverse events recommends emergency department evaluation for anyone experiencing hallucinations, moderate-to-severe agitation, abnormal muscle movements, chest pain, loss of consciousness, or seizures.4PubMed. Methylphenidate poisoning: an evidence-based consensus guideline for out-of-hospital management Hallucinations alone, even without other dangerous symptoms, clear that threshold. If a child is seeing things that are not there and is frightened, an ER visit is appropriate, both for medical evaluation and to rule out other causes.
At the hospital, the standard workup aims to exclude causes beyond the medication itself. Clinicians will want to ensure there has not been an accidental overdose, a drug interaction, or an unrelated condition mimicking psychotic symptoms. In the vast majority of methylphenidate cases, the answer turns out to be straightforward: the drug triggered it, and removing the drug fixes it.
Symptoms Almost Always Resolve After Stopping
The reassuring finding across the published literature is that methylphenidate-induced hallucinations go away when the medication is discontinued.5PubMed. Methylphenidate-induced visual hallucinations This is not a situation where stopping the drug leaves behind lasting perceptual problems. The resolution tends to be quick, often within hours to days of the last dose, depending on which formulation was being used. Extended-release versions stay in the system longer, so symptoms may linger a bit compared to immediate-release pills, but the trajectory is the same.
For parents especially, this is the critical point: a frightening episode of hallucinations in a child on methylphenidate does not mean the child has developed a psychotic illness. It means the child had an adverse drug reaction. The distinction matters enormously for what comes next, both medically and emotionally.
How Common This Actually Is
Stimulant-induced psychotic symptoms are uncommon, but they are not so rare that you should be shocked if it happens. A systematic review and meta-analysis published in 2025 found that roughly 2.8% of people with ADHD who are prescribed stimulants develop some form of psychotic symptoms.6JAMA Psychiatry. Occurrence of Psychosis and Bipolar Disorder in Individuals With Attention-Deficit/Hyperactivity Disorder Treated With Stimulants: A Systematic Review and Meta-Analysis That figure pools both methylphenidate and amphetamine users together and includes a wide range of psychotic symptoms, not just hallucinations. Importantly, the same meta-analysis found the risk was significantly lower with methylphenidate than with amphetamines.
The FDA has received over 800 postmarketing reports of psychosis or mania associated with ADHD medications in children, and about 90% of those cases involved people with no prior history of any similar psychiatric condition.1Pediatrics. Hallucinations and Other Psychotic Symptoms Associated With the Use of Attention-Deficit/Hyperactivity Disorder Drugs in Children That last detail is unsettling: this is not something that only happens to people who were already on the edge of psychosis. It can happen to someone with a completely clean psychiatric history, including young children.
A large study tracking over 20,000 children and adolescents with methylphenidate prescriptions found an overall incidence of psychotic events during treatment of about 6 per 10,000 patient-years.7PubMed Central. Methylphenidate and the risk of psychotic disorders and hallucinations in children and adolescents in a large health system That study also found something surprising: the rate of psychotic events was actually higher in the period just before methylphenidate was started than during treatment itself. One interpretation is that some of these psychotic episodes reflect the underlying psychiatric distress that led to the ADHD evaluation in the first place, rather than the drug.
Methylphenidate Versus Amphetamines
If your prescriber is discussing whether to try a different stimulant after an episode of hallucinations, the choice between methylphenidate and an amphetamine-based drug is relevant. A large matched-cohort study published in the New England Journal of Medicine found that psychosis episodes occurred in about 1 in 1,000 methylphenidate users compared with about 2 in 1,000 amphetamine users, giving amphetamines roughly 65% higher risk.8PubMed Central. Psychosis with Methylphenidate or Amphetamine in Patients with ADHD The 2025 meta-analysis reached a similar conclusion, with amphetamines carrying about 57% higher odds of psychosis than methylphenidate.6JAMA Psychiatry. Occurrence of Psychosis and Bipolar Disorder in Individuals With Attention-Deficit/Hyperactivity Disorder Treated With Stimulants: A Systematic Review and Meta-Analysis
This does not mean switching from methylphenidate to an amphetamine makes sense after a psychotic episode on methylphenidate. If anything, it means the opposite. But it is worth knowing that if someone experienced hallucinations on an amphetamine, a switch to methylphenidate might carry a lower risk. These are conversations for the prescriber, not decisions to make alone, but understanding the relative risk helps you ask better questions.
Whether You Can Go Back on Stimulants Later
This is the question that worries most families. ADHD is a real problem in daily life, and if the medication that was helping with focus and self-regulation has just caused a terrifying side effect, the prospect of losing that treatment tool is daunting. The evidence here is genuinely encouraging.
A commentary in The Lancet Psychiatry summarized clinical experience with patients who had developed psychotic symptoms on stimulant medications. After discontinuation and a washout period ranging from one to sixteen months, patients were restarted on stimulant medication at very low initial doses and titrated up slowly with close monitoring. All participants in those cases benefited from the reintroduction, experienced few adverse events, and had no reoccurrence of psychotic symptoms.9The Lancet Psychiatry. ADHD medication treatment and risk of psychosis That is a small body of evidence, not a guarantee, but it suggests that a single episode of drug-induced hallucinations does not permanently close the door on stimulant treatment.
A separate population-based cohort study looked at the risk of psychotic events before and after methylphenidate was started in adolescents and young adults. One year after treatment initiation, the rate of psychotic events had actually dropped by about 36% among those who had a prior history of psychosis, compared to the period just before treatment began.10The Lancet Psychiatry. Methylphenidate and the risk of psychosis in adolescents and young adults: a population-based cohort study In other words, for many people, ongoing methylphenidate treatment did not increase long-term psychosis risk and may have been associated with lower risk over time. The careful, gradual reintroduction approach described above is the key to making that work safely.
What About Non-Stimulant Alternatives
If the prescriber decides stimulants should be avoided entirely, there are non-stimulant medications for ADHD, including atomoxetine, guanfacine, and clonidine. These work through different brain pathways and are not generally associated with the same hallucination risk as stimulants. However, an interesting wrinkle showed up in a study of adults with ADHD: the absolute risk of a first psychiatric hospitalization for psychosis or mania within a year of starting ADHD medication was actually highest with atomoxetine (about 0.6%), compared with amphetamines (about 0.3%) and methylphenidate (about 0.2%).11BMJ Mental Health. Risk of hospitalisation for first-onset psychosis or mania within a year of ADHD medication initiation in adults with ADHD That result likely reflects the population being prescribed atomoxetine rather than the drug itself. Clinicians may preferentially prescribe atomoxetine to people they already consider higher-risk for stimulant side effects, including people with a history of psychosis or substance use. But it is a reminder that “non-stimulant” does not automatically mean “zero psychiatric risk.”
Guanfacine and clonidine are alpha-2 agonists originally developed for blood pressure. They tend to be milder overall and carry a lower burden of psychiatric side effects, though they are also less effective for core ADHD symptoms in many people. Behavioral therapy and environmental accommodations also remain part of the picture, especially for children. None of these alternatives replicate the effect of stimulants for most people, which is why cautious reintroduction of stimulants often remains on the table even after a psychotic episode.
Why Most Cases Come Out of Nowhere
One of the more unsettling aspects of this side effect is that it tends to strike without warning. The FDA-analyzed clinical trial data showed that in about 90% of postmarketing cases, the person had no prior history of psychotic symptoms.1Pediatrics. Hallucinations and Other Psychotic Symptoms Associated With the Use of Attention-Deficit/Hyperactivity Disorder Drugs in Children There is no reliable screening test to predict who will have this reaction. Family history of psychotic disorders may raise suspicion, and prescribers should ask about it, but most children who experience stimulant-induced hallucinations have unremarkable family and personal psychiatric histories.
This unpredictability is part of why an expert panel recommended that all ADHD medications come with consumer-friendly medication guides distributed by pharmacists, specifically to warn patients and families about cardiovascular and psychiatric risks including hallucinations.12American Journal of Health-System Pharmacy. Experts advise med guides for ADHD drugs The goal is not to frighten people away from effective treatment but to make sure families recognize the symptoms quickly and know to stop the medication rather than push through, wondering if the child is just “being dramatic.”
It is also worth knowing that not every unusual perception on methylphenidate is a hallucination. Some children report mild perceptual changes, vivid daydreams, or heightened sensory sensitivity that fall short of seeing or feeling things that are not there. These milder experiences are more common and do not carry the same clinical significance. The threshold that should prompt a call to the prescriber is clear: if someone is perceiving things that are not present, especially insects, animals, or other entities, that counts as a hallucination regardless of whether the person can tell it is not real.
How to Talk to a Child After an Episode
When a child experiences drug-induced hallucinations, the psychological aftermath can persist even after the perceptions stop. A seven-year-old who spent an evening convinced that bugs were crawling on the walls may develop anxiety about bedtime, reluctance to take any medication, or fear that “it will happen again.” These reactions are normal, and they deserve direct attention.
The most helpful thing you can do is name what happened in age-appropriate terms. The medicine made your brain see something that was not really there. It was not your fault, you were not going crazy, and the medicine has been stopped so it will not happen again from that same cause. Avoid minimizing the experience (“it was just your imagination”) because the child experienced something viscerally real to them, and dismissing it can erode trust. At the same time, avoid catastrophizing. Children take cues from parental anxiety, and framing this as a known, manageable side effect rather than a medical crisis helps the child process it.
If anxiety or sleep disturbance persists for more than a couple of weeks after the medication is stopped, let the prescriber know. Brief therapeutic support may help, particularly for children who develop avoidance behaviors around medication or bedtime. Most children recover fully and quickly, but a small number may need help putting the experience in context.
Dosage, Timing, and Formulation Considerations
Published case reports describe hallucinations occurring across a range of doses, including the very first low dose a patient receives.2PubMed. Methylphenidate induction of complex visual hallucinations There is no consistent evidence that higher doses carry a proportionally higher risk of this specific side effect. The large cohort study that followed over 20,000 children included all formulations and strengths of methylphenidate, both standard and extended-release.7PubMed Central. Methylphenidate and the risk of psychotic disorders and hallucinations in children and adolescents in a large health system The fact that hallucinations can happen at starter doses on the first day means that dose reduction alone is unlikely to be the solution if they have already occurred. Discontinuation, not dose adjustment, is the standard response.
That said, when stimulants are cautiously reintroduced after a washout period, the low-and-slow approach to dosing is exactly the strategy that has been reported to succeed. Starting at a lower dose than the one that originally caused the problem, and titrating up over weeks or months with careful monitoring, appears to reduce the chance of a repeat episode.9The Lancet Psychiatry. ADHD medication treatment and risk of psychosis The distinction is between acute management, where the right move is to stop entirely, and long-term planning, where gradual reintroduction may be appropriate under medical supervision.
One practical detail worth noting about the study of hospitalizations for first-onset psychosis: among adults who were hospitalized and later represcribed their ADHD medication, about a quarter had to be readmitted for psychosis or mania.11BMJ Mental Health. Risk of hospitalisation for first-onset psychosis or mania within a year of ADHD medication initiation in adults with ADHD That is a meaningful recurrence rate and underscores why reintroduction needs to happen with close follow-up, not a casual “let’s try it again and see.” The majority did fine, but the minority who did not is large enough that vigilance matters.